default author photo

Jianhua Yu

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023

China

SCHOLARLY PAPERS

2

DOWNLOADS

442

TOTAL CITATIONS

4

Scholarly Papers (2)

1.

Clinical Characteristics of 60 COVID-19-Infected Patients with or Without Renal Injury In Hangzhou, China

Number of pages: 18 Posted: 20 Feb 2020
Zhejiang Chinese Medical University, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou and Zhejiang Chinese Medical University
Downloads 288 (263,338)
Citation 2

Abstract:

Loading...

cross-sectional, descriptive study; Clinical Characteristics; COVID-19; renal Injury

2.

Efficacy and Safety of Long Acting HIV Fusion Inhibitor Albuvirtide in Antiretroviral-Experienced Adults with HIV-1: Interim 48 Week Results from the Randomized, Controlled, Phase 3 Trial, Non-Inferiority TALENT Study

Number of pages: 27 Posted: 08 Jan 2019
Capital Medical University - Beijing YouAn Hospital, Frontier Biotechnologies Inc., Capital Medical University, Fudan University - Department of Radiology, Government of the People's Republic of China - Tangdu Hospital, The First Hospital of Changsha, Southern University of Science and Technology - Shenzhen Third People's Hospital, Central South University - Second Xiangya Hospital, Zhejiang University - First Affiliated Hospital, Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou, Government of the People's Republic of China - 302 Military Hospital, Capital Medical University - Beijing Ditan Hospital, Capital Medical University - Beijing YouAn Hospital, Capital Medical University - Center for Infectious Diseases, Shanghai University of Traditional Chinese Medicine, Beijing Co-CRO Medical Development Co., Ltd., Frontier Biotechnologies Inc., Frontier Biotechnologies Inc., Chinese Center for Disease Control and Prevention (China CDC) - National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - National Center for AIDS/STD Control and Prevention, Zhengzhou University, Guangzhou Medical University - Guangzhou Eighth People's Hospital, Capital Medical University - Clinical and Research Center for Infectious Diseases, Frontier Biotechnologies Inc. and Independent
Downloads 154 (482,968)
Citation 2

Abstract:

Loading...

HIV; fusion inhibitor; albuvirtide; LPV/r; non-inferiority; phase 3 clinical trial